Psycho-oncologie

SEP 18, 2026 · JOURNAL ARTICLE

Pretreatment prediction of pathological complete response and baseline psychosocial burden in HER2-positive breast cancer during neoadjuvant therapy: development and temporal internal validation of a nomogram

Psycho-oncologie

We developed and temporally internally validated a pretreatment nomogram for predicting pathological complete response (pCR) in human epidermal growth factor receptor 2 (HER2)-posi

AUG 18, 2026 · JOURNAL ARTICLE

A scoping review of high-flow nasal cannula therapy in advanced cancer: implications for quality of life, psychological well-being, and family-centered decision-making

Psycho-oncologie

A scoping review synthesizing disparate evidence on HFNC in advanced cancer with qualitative conclusions about potential benefits, but no quantitative outcomes, controlled comparisons, or meta-analysis to establish effect size.

AUG 11, 2026 · JOURNAL ARTICLE

Effects of Chaihu-Shugan-San as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma comorbid with depression: a randomized controlled trial

Psycho-oncologie

Adequately powered, double-blind RCT with validated outcome measures in a defined population, but limited to surrogate psychosocial endpoints and a single centre context without separate reporting of effect sizes or confidence intervals.